Global Cell-Free DNA (cfDNA) Testing Market Research Report 2023

Report ID: 1993902 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Donor-Derived Cell-Free DNA (DdcfDNA)
        1.2.3 Circulating Cell-Free Tumor DNA (CtDNA)
        1.2.4 Cell-Free Fetal DNA (NIPT)
    1.3 Market by Application
        1.3.1 Global Cell-Free DNA (cfDNA) Testing Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Cancer Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Cell-Free DNA (cfDNA) Testing Market Perspective (2018-2029)
    2.2 Cell-Free DNA (cfDNA) Testing Growth Trends by Region
        2.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Cell-Free DNA (cfDNA) Testing Historic Market Size by Region (2018-2023)
        2.2.3 Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2024-2029)
    2.3 Cell-Free DNA (cfDNA) Testing Market Dynamics
        2.3.1 Cell-Free DNA (cfDNA) Testing Industry Trends
        2.3.2 Cell-Free DNA (cfDNA) Testing Market Drivers
        2.3.3 Cell-Free DNA (cfDNA) Testing Market Challenges
        2.3.4 Cell-Free DNA (cfDNA) Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue
        3.1.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue (2018-2023)
        3.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Players (2018-2023)
    3.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cell-Free DNA (cfDNA) Testing Revenue
    3.4 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio
        3.4.1 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Testing Revenue in 2022
    3.5 Cell-Free DNA (cfDNA) Testing Key Players Head office and Area Served
    3.6 Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
    3.7 Date of Enter into Cell-Free DNA (cfDNA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free DNA (cfDNA) Testing Breakdown Data by Type
    4.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Type (2018-2023)
    4.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2024-2029)
5 Cell-Free DNA (cfDNA) Testing Breakdown Data by Application
    5.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Application (2018-2023)
    5.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Cell-Free DNA (cfDNA) Testing Market Size (2018-2029)
    6.2 North America Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
    6.4 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Cell-Free DNA (cfDNA) Testing Market Size (2018-2029)
    7.2 Europe Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
    7.4 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size (2018-2029)
    8.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2018-2023)
    8.4 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size (2018-2029)
    9.2 Latin America Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
    9.4 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size (2018-2029)
    10.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
    10.4 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Agilent Technology
        11.1.1 Agilent Technology Company Detail
        11.1.2 Agilent Technology Business Overview
        11.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction
        11.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.1.5 Agilent Technology Recent Development
    11.2 Allenex
        11.2.1 Allenex Company Detail
        11.2.2 Allenex Business Overview
        11.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction
        11.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.2.5 Allenex Recent Development
    11.3 Biocept
        11.3.1 Biocept Company Detail
        11.3.2 Biocept Business Overview
        11.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction
        11.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.3.5 Biocept Recent Development
    11.4 Biodesix
        11.4.1 Biodesix Company Detail
        11.4.2 Biodesix Business Overview
        11.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction
        11.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.4.5 Biodesix Recent Development
    11.5 CareDx
        11.5.1 CareDx Company Detail
        11.5.2 CareDx Business Overview
        11.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction
        11.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.5.5 CareDx Recent Development
    11.6 Guardant Health
        11.6.1 Guardant Health Company Detail
        11.6.2 Guardant Health Business Overview
        11.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction
        11.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.6.5 Guardant Health Recent Development
    11.7 Illumania
        11.7.1 Illumania Company Detail
        11.7.2 Illumania Business Overview
        11.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction
        11.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.7.5 Illumania Recent Development
    11.8 Invited
        11.8.1 Invited Company Detail
        11.8.2 Invited Business Overview
        11.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction
        11.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.8.5 Invited Recent Development
    11.9 Natera
        11.9.1 Natera Company Detail
        11.9.2 Natera Business Overview
        11.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction
        11.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.9.5 Natera Recent Development
    11.10 Quest Diagnostics
        11.10.1 Quest Diagnostics Company Detail
        11.10.2 Quest Diagnostics Business Overview
        11.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction
        11.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.10.5 Quest Diagnostics Recent Development
    11.11 Roche Holdings
        11.11.1 Roche Holdings Company Detail
        11.11.2 Roche Holdings Business Overview
        11.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction
        11.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.11.5 Roche Holdings Recent Development
    11.12 Sequenom
        11.12.1 Sequenom Company Detail
        11.12.2 Sequenom Business Overview
        11.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction
        11.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.12.5 Sequenom Recent Development
    11.13 Trovagene
        11.13.1 Trovagene Company Detail
        11.13.2 Trovagene Business Overview
        11.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction
        11.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
        11.13.5 Trovagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Donor-Derived Cell-Free DNA (DdcfDNA)
    Table 3. Key Players of Circulating Cell-Free Tumor DNA (CtDNA)
    Table 4. Key Players of Cell-Free Fetal DNA (NIPT)
    Table 5. Global Cell-Free DNA (cfDNA) Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2018-2023)
    Table 9. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2024-2029)
    Table 11. Cell-Free DNA (cfDNA) Testing Market Trends
    Table 12. Cell-Free DNA (cfDNA) Testing Market Drivers
    Table 13. Cell-Free DNA (cfDNA) Testing Market Challenges
    Table 14. Cell-Free DNA (cfDNA) Testing Market Restraints
    Table 15. Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Cell-Free DNA (cfDNA) Testing Market Share by Players (2018-2023)
    Table 17. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2022)
    Table 18. Ranking of Global Top Cell-Free DNA (cfDNA) Testing Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
    Table 22. Date of Enter into Cell-Free DNA (cfDNA) Testing Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2018-2023)
    Table 26. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2024-2029)
    Table 28. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2018-2023)
    Table 30. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2024-2029)
    Table 32. North America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Agilent Technology Company Detail
    Table 48. Agilent Technology Business Overview
    Table 49. Agilent Technology Cell-Free DNA (cfDNA) Testing Product
    Table 50. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 51. Agilent Technology Recent Development
    Table 52. Allenex Company Detail
    Table 53. Allenex Business Overview
    Table 54. Allenex Cell-Free DNA (cfDNA) Testing Product
    Table 55. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 56. Allenex Recent Development
    Table 57. Biocept Company Detail
    Table 58. Biocept Business Overview
    Table 59. Biocept Cell-Free DNA (cfDNA) Testing Product
    Table 60. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 61. Biocept Recent Development
    Table 62. Biodesix Company Detail
    Table 63. Biodesix Business Overview
    Table 64. Biodesix Cell-Free DNA (cfDNA) Testing Product
    Table 65. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 66. Biodesix Recent Development
    Table 67. CareDx Company Detail
    Table 68. CareDx Business Overview
    Table 69. CareDx Cell-Free DNA (cfDNA) Testing Product
    Table 70. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 71. CareDx Recent Development
    Table 72. Guardant Health Company Detail
    Table 73. Guardant Health Business Overview
    Table 74. Guardant Health Cell-Free DNA (cfDNA) Testing Product
    Table 75. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 76. Guardant Health Recent Development
    Table 77. Illumania Company Detail
    Table 78. Illumania Business Overview
    Table 79. Illumania Cell-Free DNA (cfDNA) Testing Product
    Table 80. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 81. Illumania Recent Development
    Table 82. Invited Company Detail
    Table 83. Invited Business Overview
    Table 84. Invited Cell-Free DNA (cfDNA) Testing Product
    Table 85. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 86. Invited Recent Development
    Table 87. Natera Company Detail
    Table 88. Natera Business Overview
    Table 89. Natera Cell-Free DNA (cfDNA) Testing Product
    Table 90. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 91. Natera Recent Development
    Table 92. Quest Diagnostics Company Detail
    Table 93. Quest Diagnostics Business Overview
    Table 94. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product
    Table 95. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 96. Quest Diagnostics Recent Development
    Table 97. Roche Holdings Company Detail
    Table 98. Roche Holdings Business Overview
    Table 99. Roche Holdings Cell-Free DNA (cfDNA) Testing Product
    Table 100. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 101. Roche Holdings Recent Development
    Table 102. Sequenom Company Detail
    Table 103. Sequenom Business Overview
    Table 104. Sequenom Cell-Free DNA (cfDNA) Testing Product
    Table 105. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 106. Sequenom Recent Development
    Table 107. Trovagene Company Detail
    Table 108. Trovagene Business Overview
    Table 109. Trovagene Cell-Free DNA (cfDNA) Testing Product
    Table 110. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
    Table 111. Trovagene Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cell-Free DNA (cfDNA) Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Cell-Free DNA (cfDNA) Testing Market Share by Type: 2022 VS 2029
    Figure 3. Donor-Derived Cell-Free DNA (DdcfDNA) Features
    Figure 4. Circulating Cell-Free Tumor DNA (CtDNA) Features
    Figure 5. Cell-Free Fetal DNA (NIPT) Features
    Figure 6. Global Cell-Free DNA (cfDNA) Testing Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2022 VS 2029
    Figure 8. Hospital Case Studies
    Figure 9. Ambulatory Surgical Centers Case Studies
    Figure 10. Cancer Research Institutes Case Studies
    Figure 11. Cell-Free DNA (cfDNA) Testing Report Years Considered
    Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Cell-Free DNA (cfDNA) Testing Market Share by Region: 2022 VS 2029
    Figure 15. Global Cell-Free DNA (cfDNA) Testing Market Share by Players in 2022
    Figure 16. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2022
    Figure 18. North America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Cell-Free DNA (cfDNA) Testing Market Share by Country (2018-2029)
    Figure 20. United States Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Cell-Free DNA (cfDNA) Testing Market Share by Country (2018-2029)
    Figure 24. Germany Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Region (2018-2029)
    Figure 32. China Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Cell-Free DNA (cfDNA) Testing Market Share by Country (2018-2029)
    Figure 40. Mexico Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Country (2018-2029)
    Figure 44. Turkey Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 47. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 48. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 49. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 50. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 51. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 52. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 53. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 54. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 55. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 56. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 57. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 58. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Frequently Asked Questions
Cell-Free DNA (cfDNA) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell-Free DNA (cfDNA) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell-Free DNA (cfDNA) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cellular Imaging

This report aims to provide a comprehensive presentation of the global market for Cellular Imagin ... Read More

Cellulose Paints

This report aims to provide a comprehensive presentation of the global market for Cellulose Paint ... Read More